A DRUG used to tackle the effects of radiation may hold the key to new treatments for tackling obesity and diabetes, scientists have said.
Experiments with the antioxidant Tempol on mice fed a high-fat diet suggest it can reduce weight gain, research published in Nature Communications journal has shown.
Mice given the drug also had lower blood sugar and insulin levels than those not given it. The research team from Penn State University and the National Cancer Institute (NCI) in the US believe it works by targeting bacteria in the gut, sparking a chain-reaction that affects the amount of fat and glucose being absorbed into the body.
Andrew Patterson, Penn State’s assistant professor of molecular toxicology, said: “We hope that this can lead to a new line of therapeutics to treat obesity and diabetes.”